GNMK News and Press, GenMark Diagnostics Inc. From 03/12/20

Predictive Oncology (NASDAQ: POAI ) +50%  on launching a new AI platform for vaccine and drug development targeting coronaviruses and acute respiratory syndromes. More news on: Predictive Oncology Inc., Chembio Diagnostics, Inc., Alpha Pro Tech, Ltd., Stocks on the move, , Read...

Shares of GenMark Diagnostics (NASDAQ: GNMK) , a company focused on molecular tests, rose as much as 30% in early morning trading on Wednesday. A lot of the early gains have since been erased, but the stock was still up about 14% as of 12:05 p.m. EDT. Today's rally is a response to the news ...

Tiziana Life Sciences PLC (NASDAQ: TLSA ) +162%  on potential coronavirus treatment . More news on: Tiziana Life Sciences PLC, Phio Pharmaceuticals Corp., Inovio Pharmaceuticals, Inc., Stocks on the move, , Read more ...

CARLSBAD, Calif., March 11, 2020 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ:GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today announced submission for an Emergency Use Authorization (EUA) to the U.S. Food and Drug Administration (FDA) f...

Shares of GenMark Diagnostics (NASDAQ: GNMK) were falling 12.7% lower as of 11:20 a.m. EST on Friday. This drop might be surprising, since the company didn't report any news and stands to benefit as the novel coronavirus outbreak drives sales for its coronavirus test kits. But it appears tha...

Digirad (NASDAQ: DRAD ) +63%  on Q4 results . More news on: Digirad Corporation, Enzo Biochem, Inc., NanoViricides, Inc., , Stocks on the move, Read more ...

The coronavirus crisis has escalated in a dramatic fashion over the course of the past few days, and that has had a massive effect on the stock markets. However, not all stocks have cratered. Companies that are involved in developing vaccines for the virus have seen their stocks soar over the ...

CARLSBAD, Calif., Feb. 18, 2020 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ:GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today announced that the company plans to participate in the upcoming Cowen Health Care Conference in Boston, Massach...

Arcturus Therapeutics (NASDAQ: ARCT ) initiated with Outperform rating and $24 (96% upside) price target at Baird. More news on: Arcturus Therapeutics Holdings Inc., Curaleaf Holdings, Inc., I-Mab, Healthcare stocks news, Stocks on the move, , Read more ...

GenMark Diagnostics (NASDAQ: GNMK ) says Hany Massarany has stepped down as President and CEO and as a board member, effective immediately. More news on: GenMark Diagnostics, Inc., Healthcare stocks news, Read more ...